[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639027":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":35,"centralContacts":39,"locations":48,"responsibleParty":70,"collaborators":10,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":75,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":10,"studyType":87,"phases":10,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":97,"whyStopped":10,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Democritus University of Thrace","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Study Group 1",null,"Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)",[13],"Drug: Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)",{"label":15,"type":10,"description":16,"interventionNames":17},"Study Group 2","Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)",[18],"Drug: Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)",{"label":20,"type":10,"description":21,"interventionNames":22},"Study Group 3","Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)",[23],"Drug: Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)",[25,29,32],{"type":26,"name":11,"description":27,"armGroupLabels":28,"otherNames":10},"DRUG","Cataract patients will be administered Drops of Sodium Hyaluronate 0.15% and Dexpanthenol 2% quid in their postoperative regimen",[9],{"type":26,"name":16,"description":30,"armGroupLabels":31,"otherNames":10},"Cataract patients will be administered Drops of Sodium Hyaluronate 0.15% and Trehalose 3% quid in their postoperative regimen",[15],{"type":26,"name":21,"description":33,"armGroupLabels":34,"otherNames":10},"Cataract patients will be administered Drops of Sodium Hyaluronate 0.2% and Amino acids quid in their postoperative regimen",[20],[36],{"name":37,"affiliation":5,"role":38},"Georgios Labiris, MD, Prof","STUDY_CHAIR",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":10,"email":44},"Eirini - Kanella Panagiotopoulou, MD, MSc, PhD","CONTACT","+30 6978730858","panagiotopoulou.ek@gmail.com",{"name":37,"role":42,"phone":46,"phoneExt":10,"email":47},"+30 2551030990","labiris@usa.net",[49],{"facility":50,"status":10,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"University Hospital of Alexandroupolis","Alexandroupoli","Evros","68100","Greece","GR",{"type":57,"coordinates":58},"Point",[59,60],25.87644,40.84995,{"lat":60,"lon":59},[63,66,68],{"name":64,"role":42,"phone":46,"phoneExt":10,"email":65},"Dimitrios Aggelonias, MSc","dangelon@affil.duth.gr",{"name":67,"role":42,"phone":10,"phoneExt":10,"email":44},"Eirini - Kanella Panagiotopoulou",{"name":41,"role":69,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":69,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Georgios Labiris","Professor of Ophthalmology","100639027","evaluation-of-the-effectiveness-of-three-tear-substitute-formulations-in-postoperative-discomfort-after-cataract-surgery-100639027",false,"NCT07581548","Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery","Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery: A Non- Interventional, Observational Study","DRY-CAT","Inclusion Criteria:\n\nDiagnosis of senile cataract with stage 2 or 3 nuclear opalescence according to the - Lens Opacities Classification System III (LOCS-3) grading scale\n\nExclusion Criteria:\n\n1. Former incisional surgery\n2. Former diagnosis of corneal disease\n3. Autoimmune diseases\n4. Mental diseases","ALL","45 Years","85 Years",{"count":85,"type":86},300,"ESTIMATED","OBSERVATIONAL","The primary objective of this study is the assessment of three tear substitute formulations in terms of postoperative discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.",[90,91],"Cataract","Dry Eye",[93,94,95,96],"dry eye","cataract surgery","sodium hyaluronate","artificial tears","NOT_YET_RECRUITING","2026-05-06",{"date":100,"type":101},"2026-05-12","ACTUAL",{"date":103,"type":86},"2026-05-01",{"date":105,"type":86},"2027-05-01",{"name":5,"class":6},1]